Develops nPulse nanosecond pulsed field ablation technology for soft tissue ablation in healthcare, including cardiac and thyroid applications.
Get notified the moment Pulse Biosciences, Inc. (PLSE) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.